JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B1293 Y-27632
39 Citation

Target: ROCK

Summary: ROCK inhibitor

≥24.7 mg/mL
A1077 Lamin fragment

Summary: Lys-Ala-Gly-Gln-Val-Val-Thr-Ile-Trp

≥100.1 mg/mL
A4007 MLN9708
6 Citation

Target: Proteasome

Summary: Proteasome inhibitor

insoluble in H2O; ≥20.85 mg/mL
A4093 ITF2357 (Givinostat)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

≥23.8 mg/mL
A4065 PF-04929113 (SNX-5422)

Target: HSP90

Summary: Hsp90 inhibitor,potent and selective

≥23.85 mg/mL
A4160 A-966492

Target: PARP

Summary: PARP-1/-2 inhibitor, highly potent

≥32.4 mg/mL
A4117 AT9283

Summary: Aurora kinase/JAK inhibitor

insoluble in H2O; ≥19.05 mg/mL
A4217 QNZ (EVP4593)
5 Citation

Summary: Potent NF-κB inhibitor
A4305 WY-14643 (Pirinixic Acid)
8 Citation

Target: PPAR

Summary: PPARα agonist,selective and highly potent

insoluble in H2O; ≥16.2 mg/mL
A4327 Tadalafil

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor

insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL